NCT01851993View on ClinicalTrials.gov

Inhaled Ondansetron & Dyspnea

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2014

Conditions
Dyspnea
Interventions
DRUG

Ondansetron

DRUG

Placebo

0.9% saline

Trial Locations (1)

H2W1S4

Clinical Exercise & Respiratory Physiology Laboratory (CERPL) of McGill University, Montreal

All Listed Sponsors
lead

McGill University

OTHER

NCT01851993 - Inhaled Ondansetron & Dyspnea | Biotech Hunter | Biotech Hunter